The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling
Open accessAbstract
Overexpression of the receptor tyrosine kinase EPH receptor A2 (EphA2) is commonly observed in aggressive breast cancer and correlates with a poor prognosis. However, while EphA2 has been reported to enhance tumorigenesis, proliferation, and MAPK activation in several model systems, other studies suggest that EphA2 activation diminishes these processes and inhibits the activity of MAPK upon ligand stimulation. In this study, we eliminated EphA2 expression in 2 transgenic mouse models of mammary carcinoma. EphA2 deficiency impaired tumor initiation and metastatic progression in mice overexpressing ErbB2 (also known as Neu) in the mammary epithelium (MMTV-Neu mice), but not in mice overexpressing the polyomavirus middle T antigen in mammary epithelium (MMTV-PyV-mT mice). Histologic and ex vivo analyses of MMTV-Neu mouse mammary epithelium indicated that EphA2 enhanced tumor proliferation and motility. Biochemical analyses revealed that EphA2 formed a complex with ErbB2 in human and murine breast carcinoma cells, resulting in enhanced activation of Ras-MAPK signaling and RhoA GTPase. Additionally, MMTV-Neu, but not MMTV-PyV-mT, tumors were sensitive to therapeutic inhibition of EphA2. These data suggest that EphA2 cooperates with ErbB2 to promote tumor progression in mice and may provide a novel therapeutic target for ErbB2-dependent tumors in humans. Moreover, EphA2 function in tumor progression appeared to depend on oncogene context, an important consideration for the application of therapies targeting EphA2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Duxbury, M. S., Ito, H., Zinner, M. J., Ashley, S. W., & Whang, E. E. (2004) · Oncogene · doi:10.1038/sj.onc.1207247 · Cited by 211
RetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Debnath, J., Muthuswamy, S. K., & Brugge, J. S. (2003) · Methods · doi:10.1016/s1046-2023(03)00032-x · Cited by 1,995
Guy, C. T., Cardiff, R. D., & Muller, W. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.954 · Cited by 1,631
Guy, C. T., Webster, M. A., Schaller, M., Parsons, T. J., Cardiff, R. D., & Muller, W. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10578 · Cited by 1,193
An Essential Role for Rho, Rac, and Cdc42 GTPases in Cell Cycle Progression Through G 1
Olson, M. F., Ashworth, A., & Hall, A. (1995) · Science · doi:10.1126/science.7652575 · Cited by 1,146
Lin, E. Y., Jones, J. G., Li, P., Zhu, L., Whitney, K. D., Muller, W. J., & Pollard, J. W. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63568-7 · Cited by 1,107
Eph receptor signalling casts a wide net on cell behaviour
Pasquale, E. B. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1662 · Cited by 1,017
Rules for Making Human Tumor Cells
Hahn, W. C., & Weinberg, R. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmra021902 · Cited by 951
Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery
Landen, C. N., Chavez-Reyes, A., Bucana, C., Schmandt, R., Deavers, M. T., Lopez-Berestein, G., & Sood, A. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0530 · Cited by 675
KLIJN, J. G. M., BERNS, P. M. J. J., SCHMITZ, P. I. M., & FOEKENS, J. A. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-3 · Cited by 597
ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini
Muthuswamy, S. K., Li, D., Lelievre, S., Bissell, M. J., & Brugge, J. S. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-785 · Cited by 554
Wikstrand, C. J., Hale, L. P., Batra, S. K., Hill, M. L., Humphrey, P. A., Kurpad, S. N., McLendon, R. E., Moscatello, D. K., Pegram, C. N., & Reist, C. J. (1995) · PubMed · Cited by 518
EphA2 overexpression causes tumorigenesis of mammary epithelial cells.
Zelinski, D. P., Zantek, N. D., Stewart, J. C., Irizarry, A. R., & Kinch, M. S. (2001) · PubMed · Cited by 463
Diverse Roles of Eph Receptors and Ephrins in the Regulation of Cell Migration and Tissue Assembly
Poliakov, A., Cotrina, M., & Wilkinson, D. G. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.09.006 · Cited by 436
The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization
Ogawa, K., Pasqualini, R., Lindberg, R. A., Kain, R., Freeman, A. L., & Pasquale, E. B. (2000) · Oncogene · doi:10.1038/sj.onc.1204004 · Cited by 380
`Eph'ective signaling: forward, reverse and crosstalk
Murai, K. K., & Pasquale, E. B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00625 · Cited by 363
Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway
Miao, H., Wei, B.-R., Peehl, D. M., Li, Q., Alexandrou, T., Schelling, J. R., Rhim, J. S., Sedor, J. R., Burnett, E., & Wang, B. (2001) · Nature Cell Biology · doi:10.1038/35074604 · Cited by 358
Timing of cyclin D1 expression within G1 phase is controlled by Rho
Welsh, C. F., Roovers, K., Villanueva, J., Liu, Y., Schwartz, M. A., & Assoian, R. K. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-950 · Cited by 323
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo
Brantley, D. M., Cheng, N., Thompson, E. J., Lin, Q., Brekken, R. A., Thorpe, P. E., Muraoka, R. S., Cerretti, D. P., Pozzi, A., Jackson, D., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205679 · Cited by 316
Self-citationInsights from transgenic mouse models of ERBB2-induced breast cancer
Ursini-Siegel, J., Schade, B., Cardiff, R. D., & Muller, W. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2127 · Cited by 269
A conditional feedback loop regulates Ras activity through EphA2
Macrae, M., Neve, R. M., Rodriguez-Viciana, P., Haqq, C., Yeh, J., Chen, C., Gray, J. W., & McCormick, F. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.07.005 · Cited by 260
Brantley-Sieders, D. M., Caughron, J., Hicks, D., Pozzi, A., Ruiz, J. C., & Chen, J. (2004) · Journal of Cell Science · doi:10.1242/jcs.01061 · Cited by 203
Self-citationAntibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior.
Carles‐Kinch, K., Kilpatrick, K. E., Stewart, J. C., & Kinch, M. S. (2002) · PubMed · Cited by 195
Muraoka, R. S., Koh, Y., Roebuck, L. R., Sanders, M. E., Brantley-Sieders, D., Gorska, A. E., Moses, H. L., & Arteaga, C. L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8691-8703.2003 · Cited by 191
Self-citationKlijn, J. G. (1992) · Endocrine Reviews · doi:10.1210/er.13.1.3 · Cited by 185
EphA2 Receptor Tyrosine Kinase as a Promising Target for Cancer Therapeutics
Ireton, R., & Chen, J. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009053765780 · Cited by 178
Self-citationAntiangiogenic and Antitumor Efficacy of EphA2 Receptor Antagonist
Dobrzanski, P., Hunter, K., Jones-Bolin, S., Chang, H., Robinson, C., Pritchard, S., Zhao, H., & Ruggeri, B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-3430-2 · Cited by 160
Muraoka-Cook, R. S., Kurokawa, H., Koh, Y., Forbes, J. T., Roebuck, L. R., Barcellos-Hoff, M. H., Moody, S. E., Chodosh, L. A., & Arteaga, C. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2111 · Cited by 159
Self-citationUeda, Y., Wang, S., Dumont, N., Yi, J. Y., Koh, Y., & Arteaga, C. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400081200 · Cited by 158
Zhuang, G., Hunter, S., Hwang, Y., & Chen, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608509200 · Cited by 156
Self-citationc-Cbl-dependent EphA2 protein degradation is induced by ligand binding.
Walker‐Daniels, J., Riese, D. J., & Kinch, M. S. (2002) · PubMed · Cited by 149
Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis
Dohn, M. R., Jiang, J., & Chen, X. (2001) · Oncogene · doi:10.1038/sj.onc.1204816 · Cited by 148
Brantley‐Sieders, D. M., Fang, W. B., Hwang, Y., Hicks, D. J., & Chen, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1560 · Cited by 145
Self-citationEph Receptor Tyrosine Kinases in Angiogenesis: From Development to Disease
Brantley‐Sieders, D. M., & Chen, J. (2004) · Angiogenesis · doi:10.1023/b:agen.0000037340.33788.87 · Cited by 145
Self-citationActivation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade
Pratt, R. L., & Kinch, M. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205758 · Cited by 145
Nuclear Factor-κB (NF-κB) Regulates Proliferation and Branching in Mouse Mammary Epithelium
Brantley, D. M., Chen, C.-L., Muraoka, R. S., Bushdid, P. B., Bradberry, J. L., Kittrell, F. S., Medina, D., Matrisian, L. M., Kerr, L. D., & Yull, F. E. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.5.1445 · Cited by 140
Guo, H., Miao, H., Gerber, L., Singh, J., Denning, M. F., Gilliam, A. C., & Wang, B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0004 · Cited by 139
Larsen, A. B., Pedersen, M. W., Stockhausen, M., Grandal, M. V., van Deurs, B., & Poulsen, H. S. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0321 · Cited by 137
Efficacy and Antivascular Effects of EphA2 Reduction With an Agonistic Antibody in Ovarian Cancer
Landen, C. N., Lu, C., Han, L. Y., Coffman, K. T., Bruckheimer, E., Halder, J., Mangala, L. S., Merritt, W. M., Lin, Y. G., Gao, C., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj414 · Cited by 136
Self-citationGe, H., Gong, X., & Tang, C. K. (2002) · International Journal of Cancer · doi:10.1002/ijc.10224 · Cited by 135
Muraoka, R. S., Lenferink, A. E. G., Law, B. K., Hamilton, E., Brantley, D. M., Roebuck, L. R., & Arteaga, C. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2204-2219.2002 · Cited by 134
Brantley‐Sieders, D. M., Fang, W. B., Hicks, D. J., Zhuang, G., Shyr, Y., & Chen, J. (2005) · The FASEB Journal · doi:10.1096/fj.05-4038fje · Cited by 129
Self-citationA kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis
Fang, W. B., Brantley‐Sieders, D. M., Parker, M. A., Reith, A. D., & Chen, J. (2005) · Oncogene · doi:10.1038/sj.onc.1208937 · Cited by 127
Self-citationEph Receptor Tyrosine Kinases in Tumor and Tumor Microenvironment
Brantley‐Sieders, D. M., Schmidt, S. K., Parker, M. A., & Chen, J. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383160 · Cited by 111
Self-citationLigation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness
Duxbury, M. S., Ito, H., Zinner, M. J., Ashley, S. W., & Whang, E. E. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.054 · Cited by 109
Expression Profiling of UVB Response in Melanocytes Identifies a Set of p53-Target Genes
Yang, G., Zhang, G., Pittelkow, M. R., Ramoni, M. F., & Tsao, H. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700470 · Cited by 108
Signal transduction in mammary tumorigenesis: a transgenic perspective
Dankort, D. L., & Muller, W. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203272 · Cited by 101
Inhibition of VEGF-Dependent Multistage Carcinogenesis by Soluble EphA Receptors
Cheng, N., Brantley, D. M., Fang, W. B., Liu, H., Fanslow, W. C., Cerretti, D. P., Bussell, K., Reith, A. D., Jackson, D., & Chen, J. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80047-7 · Cited by 100
Self-citationCell transformation by the middle T-antigen of polyoma virus
Ichaso, N., & Dilworth, S. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204859 · Cited by 92
Cheng, N., & Chen, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009147200 · Cited by 80
Self-citationBrandt, R., Eisenbrandt, R., Leenders, F., Zschiesche, W., Binas, B., Juergensen, C., & Theuring, F. (2000) · Oncogene · doi:10.1038/sj.onc.1203520 · Cited by 80
EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity.
Lü, M., Miller, K. D., Gökmen‐Polar, Y., Jeng, M., & Kinch, M. S. (2003) · PubMed · Cited by 71
Silencing the receptor EphA2 suppresses the growth and haptotaxis of malignant mesothelioma cells
Nasreen, N., Mohammed, K. A., & Antony, V. B. (2006) · Cancer · doi:10.1002/cncr.22254 · Cited by 56
Zhang, W., Ramdas, L., Shen, W., Song, S. W., Hu, L., & Hamilton, S. R. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.5.532 · Cited by 36
Spancake, K. M., Anderson, C. B., Weaver, V. M., Matsunami, N., Bissell, M. J., & White, R. L. (1999) · PubMed · Cited by 35
A Novel Mechanism for p53 to Regulate Its Target Gene ECK in Signaling Apoptosis
Jin, Y. J., Wang, J., Qiao, C., Hei, T. K., Brandt‐Rauf, P. W., & Yin, Y. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0178 · Cited by 28
Pratt, R. L., & Kinch, M. S. (2003) · PubMed · Cited by 23
Cited by
Eph-Ephrin Bidirectional Signaling in Physiology and Disease
Pasquale, E. B. (2008) · Cell · doi:10.1016/j.cell.2008.03.011 · Cited by 1,252
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
Pasquale, E. B. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2806 · Cited by 1,226
Eph Receptor Signaling and Ephrins
Lisabeth, E. M., Falivelli, G., & Pasquale, E. B. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009159 · Cited by 425
Therapeutic targeting of EPH receptors and their ligands
Boyd, A. W., Bartlett, P. F., & Lackmann, M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4175 · Cited by 341
The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting
Wykosky, J., & Debinski, W. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0244 · Cited by 300
Metadata
- Authors
- Brantley-Sieders, D. M., Zhuang, G., Hicks, D., Fang, W. B., Hwang, Y., Cates, J. M. M., Coffman, K., Jackson, D., Bruckheimer, E., Muraoka-Cook, R. S., & Chen, J.
- Venue
- Journal of Clinical Investigation
- Published
- 2008-01-02
- Volume
- 118
- Issue
- 1
- Pages
- 64-78
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2000000810
- Cited by
- 278
- References
- 62
- FWCI
- 10.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.